Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CASP1 | P29466 | 2/20 | 1.00 |
| ▸ | CASP7 | P55210 | 2/20 | 1.00 |
| ▸ | CA9 | Q16790 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | KDR | P35968 | 3/20 | 0.67 |
| ▸ | NUAK1 | O60285 | 2/20 | 0.67 |
| ▸ | IGF1R | P08069 | 2/20 | 0.67 |
| ▸ | PIM1 | P11309 | 2/20 | 0.67 |
| ▸ | SRC | P12931 | 2/20 | 0.67 |
| ▸ | PLK1 | P53350 | 2/20 | 0.67 |
| ▸ | PKN1 | Q16512 | 2/20 | 0.67 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.67 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | CLK2 | P49760 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 5/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 5,7-Dihydroxy-4-Methylcoumarin SCHEMBL29431030 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| 5,7-Dihydroxy-4-Methylcoumarin SCHEMBL4395631 | 0.98 | ALDH1A1 (0.96) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| SCHEMBL5118377 | 0.93 | ALDH1A1 (0.86) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| SCHEMBL11215292 | 0.89 | ALDH1A1 (0.79) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| SCHEMBL12457526 | 0.85 | ALDH1A1 (0.74) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| Formaldehyde SCHEMBL27728506 | 0.85 | ALDH1A1 (0.74) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| SCHEMBL536984 | 0.84 | ALDH1A1 (0.72) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| SCHEMBL22031602 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| SCHEMBL6904702 | 0.82 | ALDH1A1 (0.70) | ALDH1A1HPGDHSD17B10TSHRCASP1 | |
| SCHEMBL5337247 | 0.81 | ALDH1A1 (0.69) | ALDH1A1HPGDHSD17B10TSHRCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421419-B2 | Preparation method for ultraviolet-responsive coumarin controlled-release and self-repairing anti-fouling paint | Quzhou Research Institute of Zhejiang University (CN) | 2025-09-23 | — | — | US | claimed |
| WO-2024209462-A1 | ANTI-BIOFILM POLYMER COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-10-10 | — | — | WO | claimed |
| CN-116333564-B | Fluorescent epoxy emulsion, preparation method thereof and epoxy fluorescent paint | 江苏丰彩建材(集团)有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-115124679-B | Self-repairing hyperbranched waterborne polyurethane and preparation method and application thereof | 陕西科技大学 | 2023-09-12 | — | — | CN | claimed |
| CN-116672289-A | Leaf extract of white mustard and application thereof in preparing cosmetics | 西藏藏医药大学 | 2023-09-01 | — | — | CN | claimed |
| CN-115851110-B | Preparation method of light response long-acting super-lubricating anti-fouling paint based on coumarin | 浙江大学 | 2023-08-15 | — | — | CN | claimed |
| CN-116478361-A | Self-repairing antibacterial aqueous polyurethane and preparation method and application thereof | 陕西科技大学 | 2023-07-25 | — | — | CN | claimed |
| US-20230212419-A1 | PREPARATION METHOD FOR ULTRAVIOLET-RESPONSIVE COUMARIN CONTROLLED-RELEASE AND SELF-REPAIRING ANTI-FOULING PAINT | Quzhou Research Institute of Zhejiang University (CN) | 2023-07-06 | — | — | US | claimed |
| CN-116333564-A | Fluorescent epoxy emulsion, preparation method thereof and epoxy fluorescent paint | 江苏丰彩建材(集团)有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-115851110-A | Preparation method of coumarin-based photoresponse long-acting super-lubricating antifouling paint | 浙江大学 | 2023-03-28 | — | — | CN | claimed |
| WO-2017165464-A1 | MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF | ELSTAR THERAPEUTICS, INC. (US) | 2017-09-28 | — | — | WO | claimed |
| CN-104411324-A | Combination therapy using anti-hyaluronan agents and tumor-targeted taxanes | HALOZYME INC | 2015-03-11 | — | — | CN | claimed |
| EP-2833905-A1 | COMBINATION THERAPY WITH AN ANTI - HYALURONAN AGENT AND A TUMOR - TARGETED TAXANE | Halozyme, Inc. (US) | 2015-02-11 | — | — | EP | claimed |
| WO-2014062856-A1 | HYPOXIA AND HYALURONAN AND MARKERS THEREOF FOR DIAGNOSIS AND MONITORING OF DISEASES AND CONDITIONS AND RELATED METHODS | HALOZYME, INC. (US) | 2014-04-24 | — | — | WO | claimed |
| WO-2013151774-A1 | COMBINATION THERAPY WITH AN ANTI - HYALURONAN AGENT AND A TUMOR - TARGETED TAXANE | HALOZYME, INC. (US) | 2013-10-10 | — | — | WO | claimed |
| US-20120020951-A1 | Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects | HALOZYME, INC. | 2012-01-26 | — | — | US | claimed |
| CN-101792472-A | Method for synthesis of aryl rhamnoside | UNIV EAST CHINA NORMAL | 2010-08-04 | — | — | CN | claimed |
| WO-2006024545-A1 | FUSED BICYCLIC NATURAL COMPOUNDS AND THEIR USE AS INHIBITORS OF PARP AND PARP-MEDIATED INFLAMMATORY PROCESSES | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2006-03-09 | — | — | WO | claimed |
| WO-1996031206-A2 | FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1996-10-10 | — | — | WO | claimed |
| US-4128428-A | ORGANIC SILVER SALT, N-HALO COMPOUND, REDUCING AGENT, IRON COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1978-12-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120020951-A1 | Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects | ENGASE, HPSE, GUSB | ALDH1A1 474/4885HPGD 353/4885HSD17B10 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.